Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study

BACKGROUND: To retrospectively analyze the efficacy and safety of concurrent chemoradiotherapy (CCRT) plus recombinant human endostatin (Endostar, CCRT + E) versus CCRT alone in locally advanced nasopharyngeal carcinoma (LANPC). METHODS: A retrospective analysis of patients initially treated for LAN...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yuanxiu, Zhou, Ziyan, Li, Zhiru, Shen, Mingjun, Qin, Yating, Yang, Chaolin, Wang, Rensheng, Kang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338543/
https://www.ncbi.nlm.nih.gov/pubmed/35906636
http://dx.doi.org/10.1186/s13014-022-02104-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338543/
https://www.ncbi.nlm.nih.gov/pubmed/35906636
http://dx.doi.org/10.1186/s13014-022-02104-4

Ejemplares similares